Adolescent tuberculosis.

Kathryn J Snow; Andrea T Cruz; James A Seddon; Rashida A Ferrand ORCID logo; Silvia S Chiang; Jennifer A Hughes; Beate Kampmann ORCID logo; Steve M Graham; Peter J Dodd; Rein M Houben ORCID logo; +3 more... Justin T Denholm; Susan M Sawyer; Katharina Kranzer ORCID logo; (2019) Adolescent tuberculosis. The Lancet Child & Adolescent Health, 4 (1). pp. 68-79. ISSN 2352-4642 DOI: 10.1016/S2352-4642(19)30337-2
Copy

Adolescence is characterised by a substantial increase in the incidence of tuberculosis, a known fact since the early 20th century. Most of the world's adolescents live in low-income and middle-income countries where tuberculosis remains common, and where they comprise a quarter of the population. Despite this, adolescents have not yet been addressed as a distinct population in tuberculosis policy or within tuberculosis treatment services, and emerging evidence suggests that current models of care do not meet their needs. This Review discusses up-to-date information about tuberculosis in adolescence, with a focus on the management of infection and disease, including HIV co-infection and rifampicin-resistant tuberculosis. We outline the progress in vaccine development and highlight important directions for future research.


picture_as_pdf
Adolescent-Tuberculosis.pdf
subject
Accepted Version
Available under Creative Commons: NC-ND 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads